Pasquale Santangeli, MD
Clinical Cardiac Electrophysiology · Philadelphia, PANPI 1609132257
Payments from drug & device makers
What this record shows
The money is spread across several categories — consulting fees (49.4%), speaking fees and travel and lodging — rather than concentrated in one kind of arrangement. 23 manufacturers reported payments, led by Abbott at 55.7% of the total. Reporting peaked in 2019 at $128,041 and has fallen 92.1% since, to $10,101 in 2025. Among clinical cardiac electrophysiology clinicians in PA with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 732 payments — averaging $793.96 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Abbott$324K
- Boston Scientific$74K
- Medical Device Business Services, Inc.$54K
- Biotronik Inc.$49K
- Medtronic$32K
- Baylis Medical Company Inc$18K
- plus $30K from 17 others
Across 53 payments — averaging $13,864 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Medical Device Business Services, Inc.$257K
- Biosense Webster, Inc.$214K
- Boston Scientific$164K
- Medtronic$71K
- Abbott$29K
What the payments were for
- Consulting fees$286,93549%
- Speaking & faculty fees$180,39131%
- Travel & lodging$89,14115%
- Food & beverage$24,7124%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Abbott | 399 | $323,599 |
| Boston Scientific | 82 | $73,838 |
| Medical Device Business Services, Inc. | 27 | $53,990 |
| Biotronik Inc. | 70 | $48,627 |
| Medtronic(2 entities) | 90 | $32,463 |
| Baylis Medical Company Inc | 9 | $18,326 |
| Biosense Webster, Inc. | 22 | $11,816 |
| Abiomed | 2 | $6,550 |
| Biosig Technologies, Inc. | 5 | $6,500 |
| Stereotaxis Inc | 2 | $2,081 |
| Siemens Medical Solutions USA, Inc. | 1 | $1,000 |
| Asahi Intecc USA, Inc. | 1 | $900 |
| Acutus Medical, Inc. | 3 | $341 |
| Elutia, Inc. | 2 | $300 |
| Merit Medical Systems Inc | 1 | $200 |
| ZOLL Services LLC (a/k/a ZOLL Lifecor Corp) | 2 | $184 |
| Cardiva Medical, Inc. | 3 | $142 |
| Impulse Dynamics (USA) Inc. | 4 | $92 |
| Volta Medical Inc | 1 | $83 |
| Johnson & Johnson(2 entities) | 3 | $62 |
| Bardy Diagnostics, Inc. | 1 | $50 |
| Vektor Medical Inc. | 1 | $19 |
| Philips North America LLC | 1 | $17 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- ENSITE PRECISION$74,938
- ENSITE$69,152
- Ensite Cardiac Mapping System$63,319
- Carto 3$50,230
- Advisor Catheter$47,657
- EnSite Precision Cardiac Mapping System$31,313
- VersaCross Access Solution$29,126
- Farapulse$22,500
- Solia$16,194
- BioMonitor$16,194
- TactiCath Quartz CFA Catheter$15,353
- Carto 3 System$14,854
- Rivacor 7 DR-T$14,031
- Edora 8 DR-T$14,031
- Acticor 7 VR-T DX$14,031
- Agilis NxT EP Introducer$7,350
- Impella$6,550
- Acticor$5,592
- Edora$5,592
- Rivacor$5,592
How this compares
$581,178 in reported general payments places this provider in the 95th percentile of 201 clinical cardiac electrophysiology providers in Pennsylvania.
See all clinical cardiac electrophysiology providers in Pennsylvania →
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| EliquisApixaban | 185 | $235,328 |
| XareltoRivaroxaban | 20 | $30,218 |
| Dofetilide | 52 | $20,118 |
| Flecainide Acetate | 57 | $3,535 |
| Amiodarone Hcl | 61 | $2,594 |
| Metoprolol Succinate | 70 | $1,638 |
| Nadolol | 12 | $816 |
| Diltiazem 24hr Er (Cd)Diltiazem Hcl | 28 | $697 |
| SotalolSotalol Hcl | 19 | $346 |
| Metoprolol Tartrate | 38 | $229 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Johnson & JohnsonXarelto | $62 | $30,21820 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 201 clinical cardiac electrophysiology providers in Pennsylvania.
Other clinical cardiac electrophysiology in Philadelphia
- Fermin GarciaPhiladelphia$684K
- Ralph VerdinoPhiladelphia$682K
- Francis MarchlinskiPhiladelphia$469K
- Joshua CooperPhiladelphia$405K
- Timothy MarkmanPhiladelphia$402K
- David CallansPhiladelphia$350K
- Robert SchallerPhiladelphia$333K
- Matthew HymanPhiladelphia$294K
- David FrankelPhiladelphia$218K
- Rajat DeoPhiladelphia$148K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.